Sign up to save your podcasts
Or
Share Clinical Innovation in AML
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Clinical Innovation in AML
CME credits: 0.50
Valid until: 30-09-2023
Claim your CME credit at https://reachmd.com/programs/cme/clinical-innovation-in-aml/14103/
Developments over the last few years have brought dramatic changes to the treatment landscape of acute myeloid leukemia (AML). While new therapies mean more opportunities to individualize care, clinicians are also faced with new challenges and must quickly evaluate patients, order appropriate molecular tests, assess risk, and differentiate the efficacy, safety, and applicability of novel treatments and combinations. Join Drs. Courtney DiNardo and Marina Konopleva for a discussion of how to untangle the data to determine which treatment is right for each patient in the increasingly complex clinical setting of AML.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.50
Valid until: 30-09-2023
Claim your CME credit at https://reachmd.com/programs/cme/clinical-innovation-in-aml/14103/
Developments over the last few years have brought dramatic changes to the treatment landscape of acute myeloid leukemia (AML). While new therapies mean more opportunities to individualize care, clinicians are also faced with new challenges and must quickly evaluate patients, order appropriate molecular tests, assess risk, and differentiate the efficacy, safety, and applicability of novel treatments and combinations. Join Drs. Courtney DiNardo and Marina Konopleva for a discussion of how to untangle the data to determine which treatment is right for each patient in the increasingly complex clinical setting of AML.
=